West Pharmaceutical Services, Inc. (WST)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 277.16 |
| Open | 279.63 |
| Bid | 286.28 x 800 |
| Ask | 284.10 x 900 |
| Day's range | 275.49 - 289.45 |
| 52-week range | 265.00 - 415.73 |
| Volume | |
| Avg. volume | 625,295 |
| Market cap | 20.743B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 40.45 |
| EPS (TTM) | 7.04 |
| Earnings date | 24 Oct 2024 - 28 Oct 2024 |
| Forward dividend & yield | 0.80 (0.29%) |
| Ex-dividend date | 31 Jul 2024 |
| 1y target est | 394.07 |
ZacksWest Pharmaceutical (WST) Misses on Q2 Earnings, Lowers '24 View
West Pharmaceutical's (WST) second-quarter results reflect a declining demand for products across its segments amid elevated customer destocking.
ZacksWest Pharmaceutical Services (WST) Q2 Earnings and Revenues Miss Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of -14.12% and 4.83%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press Finance
West Pharmaceutical: Q2 Earnings Snapshot
On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.51. Earnings, adjusted for amortization costs, were $1.52 per share. The results missed Wall Street expectations.
© 2024 Yahoo. All rights reserved.